Identificador persistente para citar o vincular este elemento:
https://accedacris.ulpgc.es/handle/10553/145654
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | González Lleó, Ana María | en_US |
dc.contributor.author | Brito Casillas, Yeray | en_US |
dc.contributor.author | Martin-Santana, Virginia | en_US |
dc.contributor.author | Gil Quintana, Yaiza María | en_US |
dc.contributor.author | Tugores Céster, Antonio | en_US |
dc.contributor.author | Scicali, Roberto | en_US |
dc.contributor.author | Riaño Ruiz, Marta | en_US |
dc.contributor.author | Hernández Baraza, Luisa | en_US |
dc.contributor.author | Jiménez Monzón,Roberto | en_US |
dc.contributor.author | Girona, Josefa | en_US |
dc.contributor.author | Di Giacomo Barbagallo, Francesco | en_US |
dc.contributor.author | Masana, Luis | en_US |
dc.contributor.author | Boronat Cortés, Mauro | en_US |
dc.contributor.author | Wägner, Anna Maria Claudia | en_US |
dc.contributor.author | Sanchez Hernández, Rosa María | en_US |
dc.date.accessioned | 2025-08-25T11:48:06Z | - |
dc.date.available | 2025-08-25T11:48:06Z | - |
dc.date.issued | 2025 | en_US |
dc.identifier.other | WoS | - |
dc.identifier.uri | https://accedacris.ulpgc.es/handle/10553/145654 | - |
dc.description.abstract | Background Heterozygous familial hypercholesterolemia (HeFH) is typically associated with a lower prevalence of type 2 diabetes mellitus (T2DM). However, individuals carrying the p.[Tyr400_Phe402del]LDLR mutation, which is prevalent in Gran Canaria, exhibit an unexpectedly high prevalence of T2DM. This study aimed to investigate whether the p.[Tyr400_Phe402del] LDLR mutation co-segregates with T2DM and other glucose metabolism abnormalities.MethodsA total of 226 individuals were recruited, with 196 included in the final analysis. This included 90 HeFH patients from Gran Canaria (HeFH-GC) carrying the p.[Tyr400_Phe402del]LDLR mutation, 76 first-degree relatives (non-HeFH), and 30 HeFH patients from Italy (HeFH-It) with other LDLR mutations. Clinical, anthropometric, biochemical, and hematological parameters, including insulin resistance and sensitivity, were assessed via oral glucose tolerance tests (OGTT), and indices such as HOMA-IR, HOMA-beta, QUICKI, and the triglyceride-glucose ratio were measured.ResultsAmong HeFH-GC participants, 20% had T2DM, similar to 18.4% in the non-HeFH group (p = NS). HOMA-beta was significantly greater in HeFH-GC patients (86.2 vs. 68.4; p = 0.046). Normoglycemic HeFH-GC individuals had elevated HOMA-IR [2.0 (1.3-2.9) vs. 1.3 (1.0-1.9); p = 0.008]. Compared with HeFH-It patients, HeFH-GC individuals had higher fasting glucose levels (99 vs. 92.5 mg/dL; p = 0.004) and lower 120-min post-OGTT glucose levels (115 vs. 136.5 mg/dL; p = 0.001). Lipid-lowering therapy, hypertension, hypertriglyceridemia, and increased waist circumference were associated with T2DM.ConclusionsHeFH patients from Gran Canaria exhibit a high prevalence of T2DM. The p.[Tyr400_Phe402del]LDLR mutation does not co-segregate with T2DM, but normoglycemic HeFH-GC individuals have greater insulin resistance. Additionally, lipid-lowering therapy, hypertension, hypertriglyceridemia, and increased waist circumference are factors associated with the prevalence of T2DM. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Cardiovascular Diabetology | en_US |
dc.source | Cardiovascular Diabetology [EISSN 1475-2840], v. 24 (1), (Diciembre 2025). | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320502 Endocrinología | en_US |
dc.subject | 320501 Cardiología | en_US |
dc.subject | 3205 Medicina interna | en_US |
dc.subject.other | Insulin Sensitivity | en_US |
dc.subject.other | Canary-Islands | en_US |
dc.subject.other | Gran-Canaria | en_US |
dc.subject.other | Cardiovascular Risk | en_US |
dc.subject.other | Statin Therapy | en_US |
dc.subject.other | Resistance | en_US |
dc.subject.other | Mellitus | en_US |
dc.subject.other | Disease | en_US |
dc.subject.other | Association | en_US |
dc.subject.other | Population | en_US |
dc.subject.other | Heterozygous Familial Hypercholesterolemia | en_US |
dc.subject.other | Type 2 Diabetes | en_US |
dc.subject.other | Founder Effect | en_US |
dc.subject.other | Glucose Metabolism | en_US |
dc.subject.other | Insulin Resistance Index | en_US |
dc.subject.other | Oral Glucose Tolerance Test | en_US |
dc.title | Glucose metabolism in heterozygous familial hypercholesterolemia with a founder effect and a high diabetes prevalence: a cross-sectional study | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1186/s12933-025-02857-8 | en_US |
dc.identifier.scopus | 105012751094 | - |
dc.identifier.isi | 001545422300002 | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.orcid | NO DATA | - |
dc.contributor.authorscopusid | 57203413250 | - |
dc.contributor.authorscopusid | 56236021400 | - |
dc.contributor.authorscopusid | 59367440900 | - |
dc.contributor.authorscopusid | 60032174700 | - |
dc.contributor.authorscopusid | 6701671839 | - |
dc.contributor.authorscopusid | 55322163000 | - |
dc.contributor.authorscopusid | 60032460200 | - |
dc.contributor.authorscopusid | 57966733500 | - |
dc.contributor.authorscopusid | 55329696800 | - |
dc.contributor.authorscopusid | 7005384937 | - |
dc.contributor.authorscopusid | 58166465700 | - |
dc.contributor.authorscopusid | 13805771600 | - |
dc.contributor.authorscopusid | 7003952293 | - |
dc.contributor.authorscopusid | 7401456520 | - |
dc.contributor.authorscopusid | 24767870600 | - |
dc.identifier.eissn | 1475-2840 | - |
dc.identifier.issue | 1 | - |
dc.relation.volume | 24 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.description.numberofpages | 12 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:González-Lleó, AM | - |
dc.contributor.wosstandard | WOS:Brito-Casillas, Y | - |
dc.contributor.wosstandard | WOS:Martin-Santana, V | - |
dc.contributor.wosstandard | WOS:Gil-Quintana, Y | - |
dc.contributor.wosstandard | WOS:Tugores, A | - |
dc.contributor.wosstandard | WOS:Scicali, R | - |
dc.contributor.wosstandard | WOS:Riaño, M | - |
dc.contributor.wosstandard | WOS:Hernández-Baraza, L | - |
dc.contributor.wosstandard | WOS:Jiménez-Monzón, R | - |
dc.contributor.wosstandard | WOS:Girona, J | - |
dc.contributor.wosstandard | WOS:Barbagallo, FD | - |
dc.contributor.wosstandard | WOS:Masana, L | - |
dc.contributor.wosstandard | WOS:Boronat, M | - |
dc.contributor.wosstandard | WOS:Wägner, AM | - |
dc.contributor.wosstandard | WOS:Sánchez-Hernández, RM | - |
dc.date.coverdate | Agosto 2025 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 2,621 | |
dc.description.jcr | 8,5 | |
dc.description.sjrq | Q1 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
dc.description.miaricds | 10,8 | |
item.fulltext | Sin texto completo | - |
item.grantfulltext | none | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Médicas y Quirúrgicas | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Médicas y Quirúrgicas | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.orcid | 0000-0001-8174-501X | - |
crisitem.author.orcid | 0000-0002-0707-7444 | - |
crisitem.author.orcid | 0000-0002-1849-9239 | - |
crisitem.author.orcid | 0000-0001-7761-8253 | - |
crisitem.author.orcid | 0000-0001-8535-8543 | - |
crisitem.author.orcid | 0000-0002-7663-9308 | - |
crisitem.author.orcid | 0000-0003-4991-7445 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | González Lleó, Ana María | - |
crisitem.author.fullName | Brito Casillas, Yeray | - |
crisitem.author.fullName | Gil Quintana, Yaiza María | - |
crisitem.author.fullName | Tugores Céster, Antonio | - |
crisitem.author.fullName | Riaño Ruiz, Marta | - |
crisitem.author.fullName | Hernández Baraza, Luisa | - |
crisitem.author.fullName | Jiménez Monzón,Roberto | - |
crisitem.author.fullName | Boronat Cortés, Mauro | - |
crisitem.author.fullName | Wägner, Anna Maria Claudia | - |
crisitem.author.fullName | Sanchez Hernández, Rosa María | - |
Colección: | Artículos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.